Sun Acquisitions

AUGUST 22, 2024

To mitigate these risks and build more resilient supply chains, companies are increasingly turning to strategic mergers and acquisitions (M&A). To mitigate these risks and build more resilient supply chains, companies are increasingly turning to strategic mergers and acquisitions (M&A).

M&A 52

M&A Management Mergers and Acquisitions Food 52

Global Newswire by Notified: M&A

MARCH 20, 2024

Nika Pharmaceuticals, Inc. OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc., effective as of March 1, 2024.

Pharmaceutical 89

Pharmaceutical Mergers IT 89

Global Newswire by Notified: M&A

SEPTEMBER 16, 2024

16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” PRINCETON, N.J., ANI” or “the Company”) (Nasdaq: ANIP) today announced the completion of its previously announced acquisition of Alimera Sciences, Inc. Nasdaq: ALIM) (“Alimera”).

Pharmaceutical 49

Pharmaceutical Acquisitions IT 49

JD Supra: Mergers

APRIL 23, 2024

I moderated a panel, “Structuring Your Life Sciences Transaction: Licensing vs. M&A vs. Asset Sale,” with business development leaders from GSK, Johnson & Johnson, Locust Walk, and Astria Therapeutics.

Pharmaceutical 167

Pharmaceutical M&A Sale Investors 167

Global Newswire by Notified: M&A

AUGUST 15, 2024

Protect Pharmaceutical Corp. PRTT) Announces New CEO and New Director; Moves to Finalize the Karinca Logistics Merger.

Pharmaceutical 85

Pharmaceutical Mergers 85

Global Newswire by Notified: M&A

SEPTEMBER 16, 2024

16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. PRINCETON, N.J., Nasdaq: ANIP) (“ANI” or the “Company”) announced today that the Company has initiated closing logistics for the previously announced acquisition of Alimera Sciences, Inc. Nasdaq: ALIM).

Pharmaceutical 45

Pharmaceutical Acquisitions 45

Cooley M&A

OCTOBER 19, 2022

Cooley’s M&A practice has been busy amid the typically slower summer wind down. Steaming through the third quarter, Cooley’s deal flow put us at the top of the Bloomberg, Mergermarket and Refinitiv Q3 M&A league tables. Transfer Traps: Considerations for Dual-Class Companies Contemplating M&A Transactions.

M&A 69

M&A Initial Public Offering Pharmaceutical Medical 69

Global Newswire by Notified: M&A

JULY 28, 2023

Nasdaq: BIIB) and Reata Pharmaceuticals, Inc. CAMBRIDGE, Mass. and PLANO, Texas, July 28, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. Nasdaq: RETA) today announced the companies have entered into a definitive agreement under which Biogen has agreed to acquire Reata for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3

Pharmaceutical 76

Pharmaceutical Shares 76

Global Newswire by Notified: M&A

JULY 27, 2024

New York, July 27, 2024 (GLOBE NEWSWIRE) -- NEW YORK, July 27, 2024 / GlobeNewswire/-- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report.

M&A 45

M&A Mergers Pharmaceutical Shares 45

Global Newswire by Notified: M&A

SEPTEMBER 26, 2024

Pharmaceutical Excipients Market size was valued at USD 10.12 Pharmaceutical Excipients Market size was valued at USD 10.12 billion in 2023 to USD 17.13 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031). billion in 2023 to USD 17.13 billion by 2031, growing at a CAGR of 6.8%

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

OCTOBER 21, 2024

21, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the acquisition of Aurlumyn ™ (iloprost IV), the only FDA approved treatment option for severe frostbite in the US, from CiVi Biopharma. Philadelphia, PA, Oct. Aurlumyn™ will be made available this coming winter season.

Pharmaceutical 40

Pharmaceutical Acquisitions Portfolio 40

The Harvard Law School Forum

JUNE 16, 2023

Posted by Sally Wagner Partin, Sharon Flanagan, and Hannah M. Flanagan are Partners and Hannah M. Related research from the Program on Corporate Governance includes Are M&A Contract Clauses Value Relevant to Target and Bidder Shareholders? Brown is an Associate at Sidley Austin LLP.

M&A 64

M&A Pharmaceutical Acquisitions Valuation 64

Global Newswire by Notified: M&A

OCTOBER 17, 2024

PsyLabs to exclusively supply Psyence Biomed with high purity, pharmaceutical grade psilocybin for its second development indication, Alcohol Use Disorder, as previously announced PsyLabs to exclusively supply Psyence Biomed with high purity, pharmaceutical grade psilocybin for its second development indication, Alcohol Use Disorder, as previously (..)

Pharmaceutical 40

Pharmaceutical Manufacturing IT 40

Global Newswire by Notified: M&A

SEPTEMBER 10, 2024

10, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” PRINCETON, N.J., ANI” or “the Company”) (Nasdaq: ANIP) today provided an update on the status of the completion of its previously announced acquisition of Alimera Sciences, Inc. Alimera”) (Nasdaq: ALIM).

Pharmaceutical 45

Pharmaceutical Acquisitions IT 45

Global Newswire by Notified: M&A

OCTOBER 17, 2024

AscellaHealth Announces Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services

Pharmaceutical 45

Pharmaceutical Healthcare Acquisitions IT 45

Global Newswire by Notified: M&A

JUNE 9, 2024

Selechimica”), an Italian distributor in the pharmaceutical industry. ROTTERDAM, The Netherlands (10 June 2024) – IMCD N.V. IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Italy has signed an agreement to acquire 100% of the shares in Selechimica S.R.L.

Pharmaceutical 52

Pharmaceutical IT Acquisitions Shares 52

Global Newswire by Notified: M&A

JULY 24, 2024

Westford,USA, July 24, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Pharmaceutical Packaging Market will attain a value of USD 301.23 These include designing, distributing and manufacturing packaging materials to help meet the unique needs of the pharmaceutical packaging industry. billion by 2031, with a CAGR of 9.9%

Pharmaceutical 40

Pharmaceutical Healthcare Manufacturing 40

Global Newswire by Notified: M&A

MARCH 21, 2024

March 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has acquired U.S. DEER PARK, Ill.,

Pharmaceutical 45

Pharmaceutical Acquisitions IT 45

Global Newswire by Notified: M&A

APRIL 23, 2024

a European distributor in the pharmaceutical and nutraceutical industry. ROTTERDAM, The Netherlands 24 April 2024 – IMCD N.V. IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Spain has signed an agreement to acquire 100% of the shares in Cobapharma, S.L.U,

Pharmaceutical 52

Pharmaceutical IT Acquisitions Shares 52

Global Newswire by Notified: M&A

AUGUST 19, 2024

19, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. NEW YORK, Aug. NASDAQ: TTNP) (“Titan”) today announced that it has entered into a Merger and Contribution and Share Exchange Agreement (the “Merger Agreement”) regarding a business combination with KE Sdn. The Merger Agreement was approved by Titan’s board of directors (the “Board”).

Pharmaceutical 53

Pharmaceutical Mergers Shares Business 53

Global Newswire by Notified: M&A

JULY 1, 2024

Protect Pharmaceutical Corp. Issues Corporate Update.

Pharmaceutical 49

Pharmaceutical Corporation 49

Global Newswire by Notified: M&A

DECEMBER 4, 2023

Rising demand for functional excipients and oral pharmaceutical medicines and increasing number of pharmaceuticals industries across the globe are key factors driving Pharmaceutical Excipients market revenue growth.

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

OCTOBER 4, 2024

OnKure Announces Closing of Merger with Reneo Pharmaceuticals.

Pharmaceutical 49

Pharmaceutical Mergers 49

Devensoft

JUNE 19, 2023

Mergers and acquisitions (M&A) constitute intricate and frequently risky transactions with significant implications for stakeholders. That’s why companies need to approach M&A deals with a strategic mindset that minimizes risk and maximizes value.

M&A 52

M&A Mergers and Acquisitions Mergers Management 52

Global Newswire by Notified: M&A

AUGUST 3, 2023

SkyQuest projects that the pharmaceutical contract development and manufacturing market will attain a value of USD 222.87 SkyQuest projects that the pharmaceutical contract development and manufacturing market will attain a value of USD 222.87 billion by 2030, with a CAGR of 6.9% over the forecast period (2023-2030).

Pharmaceutical 40

Pharmaceutical Manufacturing 40

Global Newswire by Notified: M&A

JANUARY 4, 2024

Rising demand for pharmaceutical drugs and increasing drug Research & Development (R&D) activities are key factors driving Active Pharmaceutical Ingredients (API) market revenue growth Rising demand for pharmaceutical drugs and increasing drug Research & Development (R&D) activities are key factors driving Active Pharmaceutical Ingredients (..)

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

JUNE 12, 2024

Westford USA, June 12, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Active Pharmaceutical Ingredients Market will attain a value of USD 351.81 Furthermore, the changing consumer taste towards personalized and precision medicine is expected to drive the active pharmaceutical ingredient (API) market. Billion by 2031, with a CAGR of 5.9%

Pharmaceutical 40

Pharmaceutical 40

Devensoft

AUGUST 22, 2023

Embracing Innovation in M&A Strategies As the M&A landscape evolves, the call for innovation grows louder. Enter freelance modeling—a dynamic concept that adapts M&A to the fast-paced, unpredictable realm of modern business. In the upcoming sections, we explore how freelance modeling reshapes M&A norms.

M&A 52

M&A Business Mergers and Acquisitions Collaboration 52

Software Equity Group

JANUARY 22, 2024

In this post, we’ll offer further insights into what’s driving the need for healthcare SaaS solutions and how business owners can capitalize on heightened activity in healthcare M&A. Few would disagree the American healthcare sector faces a great many challenges in terms of accessibility, affordability, and quality of care.

Healthcare 52

Healthcare M&A Valuation Medical 52

Software Equity Group

JANUARY 22, 2024

In this post, we’ll offer further insights into what’s driving the need for healthcare SaaS solutions and how business owners can capitalize on heightened activity in healthcare M&A. Few would disagree the American healthcare sector faces a great many challenges in terms of accessibility, affordability, and quality of care.

Healthcare 52

Healthcare M&A Valuation Medical 52

Global Newswire by Notified: M&A

MARCH 11, 2024

SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. Nasdaq: CDT ) ("Conduit Pharmaceuticals" or "Conduit") today announced the opening of cutting-edge laboratory space in Cambridge, United Kingdom, a global centre for research and development for companies at the forefront of life science innovation.

Pharmaceutical 45

Pharmaceutical Portfolio Acquisitions 45

Global Newswire by Notified: M&A

MAY 10, 2024

Nika Pharmaceuticals, Inc. NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

MAY 10, 2024

Nika Pharmaceuticals, Inc. NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

JANUARY 2, 2024

The global Pharmaceutical Packaging market size is expected to reach USD 249.41 Additionally, the rise in generic drug manufacturing, advancements in pharmaceutical technologies, and the push for sustainable and eco-friendly packaging options are also contributing factors fueling the market's growth.

Pharmaceutical 40

Pharmaceutical Healthcare Manufacturing 40

The Harvard Law School Forum

JUNE 16, 2023

Posted by Sally Wagner Partin, Sharon Flanagan, and Hannah M. Flanagan are Partners and Hannah M. Related research from the Program on Corporate Governance includes Are M&A Contract Clauses Value Relevant to Target and Bidder Shareholders? Brown is an Associate at Sidley Austin LLP.

M&A 40

M&A Pharmaceutical Acquisitions Valuation 40

Global Newswire by Notified: M&A

JANUARY 31, 2024

The global Pharmaceutical Analytical Testing Outsourcing market size is expected to reach USD 15.09 The global Pharmaceutical Analytical Testing Outsourcing market size is expected to reach USD 15.09 billion by 2030 and exhibit a CAGR of 8.4% in the forecast period (2023−2030), according to Skyquest's latest research report.

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

SEPTEMBER 26, 2024

26, 2024 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (the “Company” or “Dundee”) announced today that it has sold to a private investor 8,000 of the 1,015,008 shares it holds in TauRX Pharmaceuticals Ltd. TORONTO, Sept. TauRx”) at a price of US$125 per share for proceeds to the Company of US$1,000,000.

Pharmaceutical 40

Pharmaceutical Corporation Shares Sale 40